Oxford Nanopore Technologies

🎉 Celebrate #LaborDay with us and get ready for NCM Boston! The first 10 people to use the code 'NCM LABOR DAY' will snag a FREE ticket! We've also curated some must-see talks, check them out below.👇 Single-Cell Research Don’t miss Megan Noonan’s talk on "Nanopore transcriptomics to identify alternative splicing in renal tubule cells" and Benjamin Reiner on how "Ketamine and ECT alter prefrontal cortex cell type-specific transcriptomes." Cancer Research Explore new frontiers with Mathilde Filser on "Redefining cancer characterization via nanopore sequencing" and Stephanie Chrysanthou’s work on "Detecting germline alterations in homologous recombination repair genes." Rare Disease and clinical research Shilpa Kobren will discuss "Long-read sequencing for tough cases in the Undiagnosed Diseases Network." Plus, hear from Wanqing Shao and Svetlana Madjunkova on sequencing's role in pediatric rare disease and reproductive care respectively. Infectious disease research Samuel Shelburne will discuss "Nanopore sequencing to trace hospital infection transmission," while Ela Sauerborn will reveal "Hidden antibiotic resistance through real-time genomics." Accessibility High schooler Noah Bryan asks, "Is the water safe? The rapid test is the missing link!" Also, don’t miss Laura Kamenetzky on "Expanding long-read sequencing in southern South America. Don’t miss these groundbreaking talks at NCM Boston! Secure your ticket today and check out the rest of the agenda here: https://bit.ly/4dRyxKD #nanoporeconf

Megan Cheah from The Business Times in Singapore recently spoke to Gordon Sanghera and Kathleen C. Barnes about our growing business in Asia and partnership with Singapore’s Precise-SG100K program.   Southeast Asia is one of the most under-represented and diverse populations. By sequencing 10,000 multi-ancestry genomes, we aim to create more equity in healthcare and develop a rich library for a richer understanding of human DNA. Check out Megan's recent post and his article below.

In 2022 there were more than 474,000 new Leukaemia cases reported. Today on #WorldLeukemiaDay we highlight several researchers working tirelessly to better understand the disease, from single-cell approaches to the potential of improving detection in low- and middle-income countries. Learn more below. In her blog, Rachel Thijssen shares her research into the genetics underlying drug resistance in chronic lymphocytic leukemia. She used single-cell #nanopore sequencing to analyse clinical research samples obtained from the longest follow-up venetoclax trial ever. Read here: https://bit.ly/3B2bwG8 Time to result matters in cancer. This case study shares two different research teams' papers that described new techniques to characterise blood cancer samples faster and more comprehensively, using nanopore technology. The first highlights the potential of Cecilia Yeung and team's gene fusion reporting workflow that takes ~5 hours — which is ‘substantially faster than any current fusion detection assays used in clinical laboratories’. The second showcases research from Landau Lab and the Oxford Nanopore Applications team: GoT-Splice. GoT-Splice uses single-cell sequencing to identify, RNA splicing events and isoforms to assess the impact of somatic mutations in specific cell types. Read here: https://bit.ly/3X4ZOC0 What if you could characterise cancer with just 5 mins of sequencing? In her interview, Melanie Sagniez discusses her nanopore-sequencing-based method which accurately classified 11/12 childhood leukaemia clinical research samples. Read here: https://bit.ly/4gcYi9H In his interview, Alberto Magi discusses the role of #epigenetics in the evolution of drug resistant acute myeloid leukemias (AMLs). He also shares the impact of #nanopore sequencing on the field of #epigenetics and cancer research. Read here: https://bit.ly/4cU1kx1 Interested in learning more about nanopore sequencing and blood cancer research? Check out our Leukemia and blood cancer research playlist on YouTube. Watch here: https://bit.ly/3ze45v1

Direct RNA sequencing is unique to #nanopore technology and has many advantages over legacy sequencing technologies – such as bypassing multiple processing steps, detection of RNA modifications and poly-A tail measurement. In this blog, learn how, combined with long #nanopore reads, it’s simple to resolve full-length transcripts and quantify isoform expression dynamics, whilst identifying RNA modifications such as methylation — all with a single sequencing run. Find out more: https://lnkd.in/e4KHECGH

Philipp Rescheneder and the rest of the Applications team at Oxford Nanopore Technologies are leading the charge in developing cutting-edge bioinformatics tools designed to maximise the potential of ultra-rich nanopore data. From supporting the creation of SV caller Sniffles, and germline somatic caller Severus, to unifying workflows with #EPI2ME to provide a holistic approach to reveal more biology. Interested in learning more about analysing the ultra-rich, data generated by #nanopore sequencing? Check out Philipp's blog to read more: https://bit.ly/3zaq8Tn Curious about how these innovations can elevate your research? Join us at NCM Boston to hear the latest from Philipp and his team during the Applications team's talk. Learn more: https://bit.ly/47bs9v9 #nanoporeconf #AnythingAnyoneAnywhere

There's only 48 hours left to get yourself a phase 4 ticket for NCM Boston! Check out what we have in store during our two innovation days, biopharma day and workshops. Ticket prices increase 1st September. Get yours now: https://bit.ly/4g5p6sv #nanoporeconf

Plasmidsaurus is setting a new standard by replacing traditional Sanger sequencing with nanopore technology. With over 500 global drop boxes, they’re delivering faster, more accurate plasmid verification — essential for gene therapy and microbial engineering. This blog showcases how nanopore sequencing overcomes challenges like GC-rich regions, complex repeats and the use of primers to offer a complete view of whole plasmids — all in a single read. Learn more: https://lnkd.in/egh65AVR

Metagenomics offers the advantage of sequencing unculturable microbes and detecting elusive microorganisms that might otherwise be missed, providing a more comprehensive understanding of microbial diversity and its implications for health and disease. In this white paper, learn long nanopore reads provide greater resolution of mixed microbial samples, compared to other sequencing methods and how with real-time analysis nanopore technology provides a single platform for rapid identification and characterisation of any microbe. What you're missing matters. #WYMM Learn more https://bit.ly/4dP6yef

It was great to be part a productive week in Singapore, talking about the importance of diverse genomic datasets to improve health outcomes. Special thanks to High Commissioner Nikesh Mehta and UK in Singapore for hosting a brilliant evening that brought together leaders from across the region to promote the partnership in genomic medicine between the UK and Asia. We are inspired by the work going on in Singapore to advance understanding of the genetic diversity of multi-ethnic Asian populations, and we are proud to be part of it.

With just 3 weeks to go until NCM Boston 2024, make sure you secure a ticket before the final price increase on 1st September! Still unsure? Check out our agenda to discover the pioneering uses of #nanopore technology speakers will discuss, across an array of applications: https://bit.ly/4dskT0i